Tempus AI Acquires Paige for $81.25 Million

August 25, 2025

Tempus AI, Inc. (NASDAQ: TEM) is acquiring digital pathology company Paige for $81.25 million, primarily paid in Tempus common stock, and will assume Paige's remaining Microsoft Azure commitments. The deal expands Tempus's pathology dataset, technical team, and generative AI capabilities to accelerate development of large oncology foundation models and strengthen its precision medicine platform.

Buyers
Tempus AI, Inc.
Targets
Paige
Location
New York, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.